Works matching IS 0167594X AND DT 2022 AND VI 158 AND IP 1

Results: 14

Predictors of survival and time to progression following operative management of intramedullary spinal cord astrocytomas.
Published in:
Journal of Neuro-Oncology, 2022, v. 158, n. 1, p. 117, doi. 10.1007/s11060-022-04017-4
By:
- Hersh, Andrew M.;
- Antar, Albert;
- Pennington, Zach;
- Aygun, Nafi;
- Patel, Jaimin;
- Goldsborough III, Earl;
- Porras, Jose L.;
- Elsamadicy, Aladine A.;
- Lubelski, Daniel;
- Wolinsky, Jean-Paul;
- Jallo, George I.;
- Gokaslan, Ziya L.;
- Lo, Sheng-Fu Larry;
- Sciubba, Daniel M.
Publication type:
Article
Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients.
Published in:
Journal of Neuro-Oncology, 2022, v. 158, n. 1, p. 111, doi. 10.1007/s11060-022-04016-5
By:
- Kavouridis, Vasileios K.;
- Ligon, Keith L.;
- Wen, Patrick Y.;
- Iorgulescu, J. Bryan
Publication type:
Article
Primary CNS lymphoma of the corpus callosum: presentation and neurocognitive outcomes.
Published in:
Journal of Neuro-Oncology, 2022, v. 158, n. 1, p. 99, doi. 10.1007/s11060-022-04014-7
By:
- Nilles, Christelle;
- Delgadillo, Daniel;
- Sarazin, Marie;
- Nichelli, Lucia;
- Mokhtari, Karima;
- Mathon, Bertrand;
- Choquet, Sylvain;
- Feuvret, Loïc;
- Alentorn, Agusti;
- Ribeiro, Monica;
- Hoang-Xuan, Khê;
- Houillier, Caroline
Publication type:
Article
Comparison of the quality of death between primary malignant brain tumor patients and other cancer patients: results from a nationwide bereavement survey in Japan.
Published in:
Journal of Neuro-Oncology, 2022, v. 158, n. 1, p. 89, doi. 10.1007/s11060-022-04013-8
By:
- Aoyama, Maho;
- Masukawa, Kento;
- Sugiyama, Ikuko;
- Morita, Tatsuya;
- Kizawa, Yoshiyuki;
- Tsuneto, Satoru;
- Shima, Yasuo;
- Miyashita, Mitsunori
Publication type:
Article
LIM and SH3 protein 1 (LASP1) differentiates malignant chordomas from less malignant chondrosarcomas.
Published in:
Journal of Neuro-Oncology, 2022, v. 158, n. 1, p. 81, doi. 10.1007/s11060-022-04012-9
By:
- Vanderheijden, Cas;
- Vaessen, Thomas;
- Yakkioui, Youssef;
- Riedl, Robert;
- Temel, Yasin;
- Hovinga, Koos;
- Hoogland, Govert
Publication type:
Article
Coping with glioblastoma: prognostic communication and prognostic understanding among patients with recurrent glioblastoma, caregivers, and oncologists.
Published in:
Journal of Neuro-Oncology, 2022, v. 158, n. 1, p. 69, doi. 10.1007/s11060-022-04010-x
By:
- Walsh, Leah E.;
- Polacek, Laura C.;
- Panageas, Katherine;
- Reiner, Anne;
- Walbert, Tobias;
- Thomas, Alissa A.;
- Buthorn, Justin;
- Sigler, Allison;
- Prigerson, Holly G.;
- Applebaum, Allison J.;
- Diamond, Eli L.
Publication type:
Article
Preoperative antiepileptic drug prophylaxis for early postoperative seizures in supratentorial meningioma: a single-center experience.
Published in:
Journal of Neuro-Oncology, 2022, v. 158, n. 1, p. 59, doi. 10.1007/s11060-022-04009-4
By:
- Cai, Qing;
- Wu, Yingxi;
- Wang, Shoujie;
- Huang, Tao;
- Tian, Qilong;
- Wang, Julei;
- Qin, Huaizhou;
- Feng, Dayun
Publication type:
Article
The Clinical Frailty Scale as useful tool in patients with brain metastases.
Published in:
Journal of Neuro-Oncology, 2022, v. 158, n. 1, p. 51, doi. 10.1007/s11060-022-04008-5
By:
- Kerschbaumer, Johannes;
- Krigers, Aleksandrs;
- Demetz, Matthias;
- Pinggera, Daniel;
- Klingenschmid, Julia;
- Pichler, Nadine;
- Thomé, Claudius;
- Freyschlag, Christian F.
Publication type:
Article
Effect of distance from target on hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
Published in:
Journal of Neuro-Oncology, 2022, v. 158, n. 1, p. 41, doi. 10.1007/s11060-022-04007-6
By:
- Ironside, Natasha;
- Snyder, Harrison;
- Xu, Zhiyuan;
- Schlesinger, David;
- Chen, Ching-Jen;
- Vance, Mary Lee;
- Hong, Gregory K.;
- Jane Jr., John A.;
- Sheehan, Jason P.
Publication type:
Article
Correction to: Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma.
Published in:
2022
By:
- Shao, Naiyuan;
- Mao, Jiahao;
- Xue, Lian;
- Wang, Rong;
- Zhi, Feng;
- Lan, Qing
Publication type:
Correction Notice
High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictors.
Published in:
Journal of Neuro-Oncology, 2022, v. 158, n. 1, p. 33, doi. 10.1007/s11060-022-04004-9
By:
- DeAtkine, Andrew B.;
- Abdelrashid, Moaaz;
- Tucker, Zach;
- Mehta, Amitkumar;
- Markert, James M.;
- Kim, Jinsuh;
- Fiveash, John B.;
- Oster, Robert A.;
- Lobbous, Mina;
- Nabors, L. Burt
Publication type:
Article
High dose image-guided, intensity modulated radiation therapy (IG-IMRT) for chordomas of the sacrum, mobile spine and skull base: preliminary outcomes.
Published in:
Journal of Neuro-Oncology, 2022, v. 158, n. 1, p. 23, doi. 10.1007/s11060-022-04003-w
By:
- Chen, Andre Tsin Chih;
- Hong, Carlos Bo Chur;
- Narazaki, Douglas Kenji;
- Rubin, Virginio;
- Serante, Alexandre Ruggieri;
- Ribeiro Junior, Ulysses;
- de Lima, Luiz Guilherme Cernaglia Aureliano;
- Coimbra, Brian Guilherme Monteiro Marta;
- Cristante, Alexandre Fogaça;
- Teixeira, William Gemio Jacobsen
Publication type:
Article
The Clinical Frailty Scale as predictor of overall survival after resection of high-grade glioma.
Published in:
Journal of Neuro-Oncology, 2022, v. 158, n. 1, p. 15, doi. 10.1007/s11060-022-04001-y
By:
- Klingenschmid, Julia;
- Krigers, Aleksandrs;
- Pinggera, Daniel;
- Kerschbaumer, Johannes;
- Thomé, Claudius;
- Freyschlag, Christian F.
Publication type:
Article
LINC02381-ceRNA exerts its oncogenic effect through regulation of IGF1R signaling pathway in glioma.
Published in:
Journal of Neuro-Oncology, 2022, v. 158, n. 1, p. 1, doi. 10.1007/s11060-022-03992-y
By:
- Nemati, Hossein;
- Fakhre-Taha, Masoumeh;
- Javanmard, Amir-Reza;
- Jahanbakhshi, Amin;
- Mowla, Seyed Javad;
- Soltani, Bahram M.
Publication type:
Article